These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7684079)

  • 1. Use of somatostatin analogues in terminal cancer patients.
    Fainsinger RL; Pisani A; Bruera E
    J Palliat Care; 1993; 9(1):56-7. PubMed ID: 7684079
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders.
    Dhar A; Chawla YK
    Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin and its analogues in the therapy of gastrointestinal disease.
    Wynick D; Polak JM; Bloom SR
    Pharmacol Ther; 1989; 41(1-2):353-70. PubMed ID: 2565581
    [No Abstract]   [Full Text] [Related]  

  • 4. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies of somatostatin and somatostatin-analogues: therapeutic advances and perspectives.
    Moreau JP; DeFeudis FV
    Life Sci; 1987 Feb; 40(5):419-37. PubMed ID: 2880272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer.
    Stiefel F; Morant R
    Support Care Cancer; 1993 Jan; 1(1):57-8. PubMed ID: 7511473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of octreotide in palliative care.
    Mercadante S
    J Pain Symptom Manage; 1994 Aug; 9(6):406-11. PubMed ID: 7525789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current therapeutic possibilities with growth hormone releasing hormone and somatostatin].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1986 May; 130(20):904-8. PubMed ID: 2873514
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroendocrine disorders of the gastroenteropancreatic system. Clinical applications of the somatostatin analogue SMS 201-995. April 2-4, 1986, San Diego, California.
    Am J Med; 1986 Dec; 81(6B):1-101. PubMed ID: 2879445
    [No Abstract]   [Full Text] [Related]  

  • 10. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients.
    Srirajaskanthan R; Toumpanakis C; Karpathakis A; Marelli L; Quigley AM; Dusmet M; Meyer T; Caplin ME
    Lung Cancer; 2009 Jul; 65(1):68-73. PubMed ID: 19070398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of somatostatin and its analogs in the treatment of surgical disorders.
    Mulvihill S; Pappas TN; Passaro E; Debas HT
    Surgery; 1986 Sep; 100(3):467-76. PubMed ID: 2874618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide and the secretory effects of advanced cancer.
    Harvey FM; Dunlop RJ
    Palliat Med; 1996 Oct; 10(4):346-7. PubMed ID: 8931077
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlling symptoms in advanced cancer.
    Walsh TD; West TS
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):477-81. PubMed ID: 2450618
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is there a sensible use for somatostatin in gastroenterology?].
    Arnold R
    Internist (Berl); 1986 Nov; 27(11):697-703. PubMed ID: 2879810
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.
    Masclee AA; Jansen JB; Lamers CB
    Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia.
    Bon C; Aparicio T; Vincent M; Mavros M; Bejou B; Raynaud JJ; Zampeli E; Airinei G; Sautereau D; Benamouzig R; Michopoulos S
    Aliment Pharmacol Ther; 2012 Sep; 36(6):587-93. PubMed ID: 22831465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Well-differentiated gastric carcinoids treated with somatostatin analogues.
    Cuesta Hernández M; Gómez Hoyos E; de Miguel Novoa P; Díaz Pérez JÁ
    Endocrinol Nutr; 2013 Jan; 60(1):41-3. PubMed ID: 22483381
    [No Abstract]   [Full Text] [Related]  

  • 19. Octreotide.
    Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
    N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
    [No Abstract]   [Full Text] [Related]  

  • 20. [Somatostatin. II: Physiology, pathophysiology and clinical significance].
    Ratzmann KP; Zühlke H
    Z Gesamte Inn Med; 1981 Jan; 36(2):55-8. PubMed ID: 6111869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.